DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Revenue Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual revenue in 2023 was 893.84 Million TWD , down -5.83% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly revenue in 2024 Q3 was 193.62 Million TWD , down -13.19% from previous quarter.
  • DIVA Laboratories, Ltd. reported a annual revenue of 949.2 Million TWD in annual revenue 2022, up 33.27% from previous year.
  • DIVA Laboratories, Ltd. reported a annual revenue of 712.23 Million TWD in annual revenue 2021, down -3.35% from previous year.
  • DIVA Laboratories, Ltd. reported a quarterly revenue of 222.38 Million TWD for 2024 Q1, up 8.56% from previous quarter.
  • DIVA Laboratories, Ltd. reported a quarterly revenue of 223.04 Million TWD for 2024 Q2, up 0.3% from previous quarter.

Annual Revenue Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Revenue of DIVA Laboratories, Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 893.84 Million TWD -5.83%
2022 949.2 Million TWD 33.27%
2021 712.23 Million TWD -3.35%
2020 736.92 Million TWD 2.9%
2019 716.17 Million TWD 0.0%

Peer Revenue Comparison of DIVA Laboratories, Ltd.

Name Revenue Revenue Difference
BIONET Corp. 1.12 Billion TWD 20.71%
Genetics Generation Advancement Corp. 592.5 Million TWD -50.86%
Welgene Biotech Co.,Ltd. 280.54 Million TWD -218.608%
Puriblood Medical Co., Ltd. 125.26 Million TWD -613.545%
TFBS Bioscience Inc. 231.91 Million TWD -285.417%